The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer

Launched by SAMSUNG MEDICAL CENTER · Aug 16, 2018

Keywords

ClinConnect Summary

This clinical trial is studying how the thickness of skinfolds on the back of the arm (called triceps skinfold) may relate to how long patients live after being diagnosed with pancreatic cancer, bile duct cancer, or gallbladder cancer. Researchers want to see if measuring this skinfold can help predict survival outcomes for patients undergoing treatment, which may include surgery, chemotherapy, or supportive care.

To participate in the study, patients must be newly diagnosed with one of these types of cancer and be at least 18 years old. Unfortunately, people with other cancers, certain intestinal diseases that affect nutrient absorption, or specific psychiatric disorders like eating disorders cannot join the trial. If eligible, participants will have their triceps skinfold measured and will help researchers understand how this measurement might relate to their overall health and survival. This study is currently seeking volunteers, so it’s a great opportunity for those looking to contribute to cancer research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Newly diagnosed pancreatic, bile duct or gallbladder cancer patients, undergoing therapeutic management (including surgery, chemotherapy or palliative care).
• • Age above 18 years old
• Exclusion Criteria:
• • Other malignant disease
• • Underlying intestinal disease that cause absorprtion disorder
• • Underlying psychiatric disorder such as eating disorder (bulimia, anorexia)